BDBM235387 US10052306, 153::rac-6-(2-((3aR,5r,6aS)-5- benzyl-5- hydroxyhexahydrocyclo- penta[c]pyrrol-2(1H)-yl)- 1-hydroxyethyl)-3,4- dihydroquinolin-2(1H)- one

SMILES OC(CN1C[C@H]2C[C@](O)(Cc3ccccc3)C[C@H]2C1)c1ccc2NC(=O)CCc2c1

InChI Key InChIKey=CCNUSIXVAVLIOE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 235387   

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Cadent Therapeutics

US Patent
LigandPNGBDBM235387(rac-6-(2-((3aR,5r,6aS)-5- benzyl-5- hydroxyhexahyd...)
Affinity DataIC50: 40.2nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2018
Entry Details
Go to US Patent